Arrayit Corporation (ARYC)

[HighYieldStocks]

One of many reasons why smart investors believe $ARYC will be trading at $1+ PPS soon enough...


Arrayit Corporation Approved for Direct Medicare Billing by the Centers for Medicare and Medicaid Services

Sunnyvale, Sept. 10, 2018 (GLOBE NEWSWIRE) -- September 10, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that Arrayit’s proprietary finger stick allergy microarray test has been approved for direct Medicare billing by the Centers for Medicare and Medicaid Services (CMS). The Medicare national health insurance program provides health insurance to more than 55 million Americans annually, including 46 million seniors and 9 million younger people. CMS projects a 2018 Medicare budget of approximately $705,000,000,000 ($705 billion dollars), representing about 17% of total federal spending.




Arrayit Corporation Announces Allergy Testing Agreement with Sutter Health

Sunnyvale, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces an allergy testing agreement with Northern California healthcare leader Sutter Health. The company is providing its proprietary microarray-based finger stick allergy testing services to Sutter Health via doctors in the Sutter Health-affiliated Palo Alto Medical Foundation. Sutter Health, one of the nation’s largest healthcare networks, is headquartered in Sacramento California and has 50,000 employees including 12,000 physicians and 14,000 nurses serving 3 million Northern California patients. Sutter Health draws 19% of its revenue from the California Medical Assistance Program (Medi-Cal) and reports total patient service revenues of $12,000,000,000 ($12 billion) annually.




Arrayit Corporation Announces Allergy Testing Services Agreement with a Major Health and Wellness Provider

Sunnyvale, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces a new allergy testing services agreement with a major healthcare company specializing in patient health and wellness. Arrayit offers simple non-invasive testing services that measure reactivity of immunoglobulin E (IgE) antibodies to an extensive panel of food, environmental and specialty allergens as a precision healthcare solution to assist physicians in the diagnosis and treatment of allergy and asthma. The healthcare leader provides health and pharmacy services to more than 10 million retail, commercial and corporate customers and reports revenues exceeding $35,000,000,000 ($35 billion dollars) annually.





Recent manufacturing runs:

Arrayit manufacturing team expands weekend production and completes a $5.75 million manufacturing run for a top client commercializing finger stick microarray tests for consumer lifestyle and wellness testing in the massive $3.3 trillion healthcare markets arrayit.com/Clinical/clini


Arrayit production team completes $4.1 million microarray manufacturing run to expand inventory for major clinical healthcare accounts using our doctor-prescribed proprietary finger stick microarray tests to improve dietary and allergy health and wellness (link: http://arrayit.com/Clinical/clinical.html) arrayit.com/Clinical/clini…


Arrayit production team expands manufacturing adding an additional overnight production run to complete a $5.0 million manufacturing run to build inventory for top accounts using our finger stick microarray allergy testing services for health and wellness (link: http://arrayit.com/Clinical/clinical.html) arrayit.com/Clinical/clini…



http://arrayit.com/index.html

https://twitter.com/arrayit

http://arrayit.com/Clinical/clinical.html